NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Under the current system, PBMs act as middlemen between manufacturers, insurers and pharmacies - inflating drug prices at the expense of patients with complex rebate and pricing structures. In ...

Drug manufacture's programs for low income ... of the Federal Trade Commission lawsuit against them for inflating insulin prices to boost their profits at the expense of vulnerable patients.

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

The Inflation Reduction Act is unlikely to generate savings for taxpayers, while disrupting the market and creating perverse ...

People with diabetes are more likely to have high cholesterol. Research suggests that insulin resistance and problems with blood sugar management can impair the way your body uses and stores fat.

The Federal Trade Commission (FTC) is asking for information from wholesalers and other middlemen in the ... “Generic prices are decreasing, drug purchasers are becoming more concentrated ...

US drug prices ... MCCPDC calls "the middlemen," namely pharmacy benefit managers (PBM) or group purchasing organisations (GPOs), who can be the source of prescription prices that are ...

Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...

2-Year U.S. Treasury Note Continuous Contract $102.664-0.035-0.03% 5-Year U.S. Treasury Note Continuous Contract $106.484-0.086-0.08% 10-Year U.S. Treasury Note Continuous Contract $109.313-0.109 ...